Gsk (GSK) Other Non-Current Assets (2009 - 2026)

Gsk (GSK) has 18 years of Other Non-Current Assets data on file, last reported at $3.6 billion in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets rose 33.48% year-over-year to $3.6 billion; the trailing twelve-month figure through Jun 2026 stood at $3.6 billion (up 33.48% YoY), and the FY2025 full-year result was $2.9 billion, up 15.1% from the prior year.
• Other Non-Current Assets was $3.6 billion for Q2 2026 at Gsk, up from $3.2 billion in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.6 billion in Q2 2026 to a low of $32.2 million in Q1 2022.
• A 5-year average of $2.2 billion and a median of $2.2 billion in 2022 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets slumped 97.64% in 2022 and jumped 5546.5% in 2023, its largest moves.
• Gsk's Other Non-Current Assets stood at $1.4 billion in 2022, then surged by 40.38% to $2.0 billion in 2023, then advanced by 26.78% to $2.5 billion in 2024, then rose by 14.63% to $2.9 billion in 2025, then grew by 24.58% to $3.6 billion in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $3.6 billion in Q2 2026, $3.2 billion in Q1 2026, and $2.9 billion in Q4 2025.